Related Experiment Video
Updated: May 28, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen
Nicholas Kwiatkowski1, Xianming Deng, Jinhua Wang
1Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States.
ACS Chemical Biology
|October 14, 2011
Summary
Researchers discovered new potent and selective Aurora kinase inhibitors using a phenotypic screen. These compounds show promise as anticancer drugs by disrupting cell division and viability in cancer cells.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Aurora kinases are crucial for cell cycle regulation and mitotic spindle assembly.
- These kinases are actively investigated as targets for novel anticancer therapies.
Purpose of the Study:
- To discover and characterize a new class of potent and selective Aurora kinase inhibitors.
- To identify key structural determinants for kinome-wide selectivity, particularly for Aurora A.
Main Methods:
- Phenotypic cellular screening to identify initial inhibitors.
- Structure-activity relationship studies guided by Aurora B co-crystal structure.
- Biochemical and cellular profiling of optimized compounds.
Main Results:
- Identification of a novel, highly potent, and selective Aurora kinase inhibitor class.
- Inhibitors induced endoreduplication, polyploidy, and cancer cell death.
- Discovery of a subseries with enhanced selectivity for Aurora A.
- Compounds 1 and 3 demonstrated valuable pharmacological profiles compared to existing inhibitors.
Conclusions:
- The newly discovered Aurora kinase inhibitors are potent and selective pharmacological tools.
- These compounds effectively inhibit Aurora kinase-dependent functions in cancer cells.
- Optimized inhibitors show potential for further development as anticancer agents.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...